Literature DB >> 8567946

Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro.

D Kaye1, D Pimental, S Prasad, T Mäki, H J Berger, P L McNeil, T W Smith, R A Kelly.   

Abstract

One of the trophic factors that has been implicated in initiating or facilitating growth in response to increased mechanical stress in several tissues and cell types is basic fibroblast growth factor (bFGF; FGF-2). Although mammalian cardiac muscle cells express bFGF, it is not known whether it plays a role in mediating cardiac adaptation to increased load, nor how release of the cytosolic 18-kD isoform of bFGF would be regulated in response to increased mechanical stress. To test the hypothesis that increased mechanical activity induces transient alterations in sarcolemmal permeability that allow cytosolic bFGF to be released and subsequently to act as an autocrine and paracrine growth stimulus, we examined primary isolates of adult rat ventricular myocytes maintained in serum-free, defined medium that were continually paced at 3 Hz for up to 5 d. Paced myocytes, but not nonpaced control cells, exhibited a "hypertrophic" response, which was characterized by increases in the rate of phenylalanine incorporation, total cellular protein content, and cell size. These changes could be mimicked in control cells by exogenous recombinant bFGF and could be blocked in continually paced cells by a specific neutralizing anti-bFGF antibody. In addition, medium conditioned by continually paced myocytes contained significantly more bFGF measured by ELISA and more mitogenic activity for 3T3 cells, activity that could be reduced by a neutralizing anti-bFGF antibody. The hypothesis that transient membrane disruptions sufficient to allow release of cytosolic bFGF occur in paced myocytes was examined by monitoring the rate of uptake into myocytes from the medium of 10-kD dextran linked to fluorescein. Paced myocytes exhibited a significantly higher rate of fluoresceinlabeled dextran uptake. These data are consistent with the hypothesis that nonlethal, transient alterations in sarcolemmal membrane permeability with release of cytosolic bFGF is one mechanism by which increased mechanical activity could lead to a hypertrophic response in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8567946      PMCID: PMC507016          DOI: 10.1172/JCI118414

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

Review 1.  Incorporation of macromolecules into living cells.

Authors:  P L Mcneil
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

2.  Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release.

Authors:  R A Steinhardt; G Bi; J M Alderton
Journal:  Science       Date:  1994-01-21       Impact factor: 47.728

3.  Culture of the terminally differentiated adult cardiac muscle cell: a light and scanning electron microscope study.

Authors:  W C Claycomb; M C Palazzo
Journal:  Dev Biol       Date:  1980-12       Impact factor: 3.582

4.  Purification of acidic fibroblast growth factor from bovine heart and its localization in the cardiac myocytes.

Authors:  H Sasaki; H Hoshi; Y M Hong; T Suzuki; T Kato; H Sasaki; M Saito; H Youki; K Karube; S Konno
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

5.  Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating.

Authors:  P Simpson
Journal:  Circ Res       Date:  1985-06       Impact factor: 17.367

6.  Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy.

Authors:  H E Shubeita; P M McDonough; A N Harris; K U Knowlton; C C Glembotski; J H Brown; K R Chien
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

7.  Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

Authors:  H Ito; Y Hirata; S Adachi; M Tanaka; M Tsujino; A Koike; A Nogami; F Murumo; M Hiroe
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy.

Authors:  M A Bogoyevitch; P E Glennon; M B Andersson; A Clerk; A Lazou; C J Marshall; P J Parker; P H Sugden
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

9.  Myosin heavy chain synthesis is independently regulated in hypertrophy and atrophy of isolated adult cardiac myocytes.

Authors:  W A Clark; S J Rudnick; L C Andersen; J J LaPres
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

10.  Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae.

Authors:  T Fujimoto; S Nakade; A Miyawaki; K Mikoshiba; K Ogawa
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

View more
  30 in total

1.  Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.

Authors:  Stacey L House; Brian E House; Betty Glascock; Thomas Kimball; Eyad Nusayr; Jo El J Schultz; Thomas Doetschman
Journal:  Mol Cell Pharmacol       Date:  2010

2.  Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation.

Authors:  Y Xia; L M Buja; R C Scarpulla; J B McMillin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Perspective on the clinical application of troponin in heart failure and states of cardiac injury.

Authors:  Almasa Bass; J Herbert Patterson; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2009-04-05       Impact factor: 4.214

4.  Increased c-fos mRNA expression by human fibroblasts contracting stressed collagen matrices.

Authors:  H Rosenfeldt; D J Lee; F Grinnell
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.

Authors:  C Pellieux; A Foletti; G Peduto; J F Aubert; J Nussberger; F Beermann; H R Brunner; T Pedrazzini
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  Fibroblast growth factor-2 mediates pressure-induced hypertrophic response.

Authors:  J E Schultz; S A Witt; M L Nieman; P J Reiser; S J Engle; M Zhou; S A Pawlowski; J N Lorenz; T R Kimball; T Doetschman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

7.  Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.

Authors:  Terumasa Hayashi; Tomonori Kimura; Keiko Yasuda; Koichi Sasaki; Yoshitsugu Obi; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-05-13       Impact factor: 2.801

8.  An A/G-rich motif in the rat fibroblast growth factor-2 gene confers enhancer activity on a heterologous promoter in neonatal rat cardiac myocytes.

Authors:  K A Detillieux; A F Meyers; J T Meij; P A Cattini
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 9.  Intramyocardial fibroblast myocyte communication.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

10.  Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice.

Authors:  R Dono; G Texido; R Dussel; H Ehmke; R Zeller
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.